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imbued with emotion, whether this is at the pre-conscious, unconscious or conscious 73 level and depicts emotion and risk as inevitably configured via social and cultural 74 processes (Lupton 2013:634) . Thus although risk may be material, as in a risk to 75 health, it is always interpreted via a social or cultural lens. Lupton describes this in 76 terms of an 'emotion-risk assemblage' that both incorporates notions of affect into 77 the concept and also identifies the ways in which the social and its cultural 78 manifestations shape risk perceptions and decision-making (ibid:636). However, 79
Lupton notes that the relationship between risk and emotion remains under 80 theorised, particularly in the context of health and medicine (ibid:637). Taking up 81
Lupton's conjecture we therefore consider both the place of emotion and social 82 influences on the choices made by kidney transplant patients when faced with a 83 biomarker test. 84 85
Our study 86
Our empirical study focuses on the process of decision-making in kidney 87 transplant patients in the context of on-going research to develop a biomarker 88 test to identify those patients who can be considered 'operationally tolerant' to 89 their graft and who will therefore not experience rejection in the absence of 90 immunosuppressive drugs (Heidt & 
Method 115
Participants for the qualitative study were purposively selected from the initial 116 quantitative patient sample to include differences in age, gender, type of transplant 117 and time on dialysis. Ethical approval was obtained for the research following which 118 a research nurse at each of the eight participating hospitals initially contacted 119 patients to establish whether they would be willing to consider taking part in the 120 study. Patients who agreed were sent a letter describing the biomarker research,M A N U S C R I P T A C C E P T E D 
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analysis were then undertaken and the data entered into the software package 146
NVivo9 to benefit from the automated search and display facilities. Each transcribed 147 interview was then worked through manually to achieve a more complete 148 understanding of the fluid and creative ways that themes emerge (Welsh 2002) . 149 150
Findings 151
The participants comprised 24 kidney transplant patients aged between 28 and 68 152 years from diverse backgrounds (Table 1) . No one characteristic appeared to 153 separate those who would take a low risk -expressed as between 0% and 5% -or 154 those willing to take a risk of 20% or more.
156
In what follows we maintain 'risk' terminology (Jackson, Allum & Gaskell 2006:2) by 157 using the concepts of 'downsides' and 'rewards' to consider participants perceptions 158 of biomarker led care. We then describe the themes of 'trust' and familial perception 159 that formed significant considerations although neither a downside nor reward. The 160 figure in parenthesis following a participant's name represents the level of risk they 161 were hypothetically prepared to take if identified as tolerant. 162 163
Downsides of the risk 164
Fear of graft failure is known to have a major influence on the lives of kidney 165 transplant patients (Howell et al 2012) and our participants similarly described how 166 the maintenance and retention of their graft was an ever-present goal. It was 167 therefore understandable that many spoke of not wishing to tamper with their 168 medication, often using idioms to capture the sense of maintaining the "status quo". Similarly for Alice (25%) the idea of "being strapped" to a dialysis machine felt like 210 "the end of my life", a "death sentence". Alice told how in order to avoid dialysis she 211 and her medical team took the risk of performing a pre-emptive kidney and pancreas 212 transplant. Jessica (2%) who was on haemodialysis also recounted dialysis in very 213 emotional and negative terms speaking of the way the transplant had "transformed" 214 her back to her "normal self". 215
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
The most common form of dialysis is haemodialysis that uses an external machine to 217 filter blood of waste products whereas peritoneal dialysis uses the inside lining of 218 the abdomen as a filter (NHS 2015b Dialysis as a downside was therefore aligned with a poorer quality of life, limited 234 freedoms affecting how participants lived their lives and challenging "normality". 235
However, the risk of a return to dialysis -even following a poor previous experience 236 -could be felt to be worthwhile if the reward was considered to be great enough. 237
For example Mark (50%) described his prior experience of being "hooked" up to a 238 machine for eight or nine hours a night as "horrendous" ….. but it was a risk he was 239 M A N U S C R I P T Although dialysis was generally viewed as a negative experience, or one to be 247 tolerated, some participants such as Georgina (35%), although not wishing to return 248 to dialysis, told us her trips to the hospital for haemodialysis had brought 249 
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Rewards of the risk 257
Whilst the disturbance of graft equilibrium, possible rejection and return to dialysis 258 were spoken of as conceivable downsides these were often balanced with the 259 imagined personal rewards of engaging with the risk. Firstly there was the reduction 260 in drug side effects. This was important for Mark (50%) and it was also important for 261 A noted type of 'reward' for taking the risk of biomarker led care was meeting the 280 emotional desires to respond to the social norms of 'gift exchange'. Whereas the 281 personal benefits of reducing immunosuppressant side effects were less common 282 than we expected it was significant that 15 of the participants described the concept 283 of "giving back" as a reason to risk biomarker led care. Patients expressed how 284 "lucky" they felt that they had been given such "an unbelievably precious gift" or a 285 M A N U S C R I P T A C C E P T E D The first is 'positional giving' which is examined through the case of giving in families 300 and similar intimate relationships. Elder-Vass describes this form of giving as 301 fundamental to family life and it can be seen in the gifting of a kidney within close 302 relationships. The second form is giving 'free gifts to strangers' (ibid:11). This we 303 argue includes the anonymous donation of living and cadaveric kidneys and the 304 willingness to be involved in clinical research from which one may not benefit. In 305 relation to our study the giving of free gifts to strangers is of particular interest in 306 two ways. Firstly having received an anonymously donated kidney many of our 307 participants expressed a desire to reciprocate in some form. When this was in theM A N U S C R I P T A C C E P T E D The question of 'why' our participants wished to reciprocate when the gift of a 317 kidney had essentially been made to a 'stranger' raises the notion of 'altruism'. 318
Whether a person is 'straightforwardly' altruistic or feels that they, or possibly 319 somebody close to them, may benefit from the altruistic act renders the concept 320 complicated. In this case gaining benefit from the 'altruistic' act of taking a high risk 321 with biomarker led care runs counter to the narrative of 'giving back' and brings in 322 the notion of self-interest that has been argued tends to devalue the act of altruism 323 (Nelkin 1998:36) . However, there is also the notion that in our participants' case 324 being willing to take a high risk is based on a form of 'interlocking obligations' where 325 a refusal to give -or in this case take a risk with biomarker led care -'is to reject the 326 bonds of alliance and commonality' (Douglas 1997:13) . In this manner altruism may 327 be seen as a calculated notion of potential benefits; an awareness of the inter-328 dependence of the system of research and medical advancement and the social 329 responsibility of the role of 'kidney transplant patient'. Hyland (2009) points out 330 that the fact that 'reciprocation' takes place over time -which requires the parties to 331 cultivate a relationship -distinguishes the gift from the mere exchange which is 332 reciprocated immediately and thus does not require, nor encourage, a continuingM A N U S C R I P T
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bond between the giver and the recipient. Refusal to reciprocate a gift is equivalent 334 to the denial of the relationship. In the case we are examining this seems very 335 plausible in terms of the close relationship that patients have with the hospital and 336 staff. From the kidney transplant patient's position the mandatory quality of the 337 counter-gift is just as integral to the nature of the gift as its unilateral quality. 338
Consequently a person who has received a kidney feels the urge to restore the 339 balance to the extent that their self-esteem may rest on a successful reciprocation. 340
Alan (50%) framed his desire in terms of "benefitting others" saying he would be 341 prepared to "go down to fifty-fifty ….. because if it killed me, the benefits would be 342 there for others": 343
344
The emotional tension between the pull to be involved in research and the wish not 345 to risk a graft is however noticeable in participant's language: As Graham (50%) 346 between a strong social desire to "help" and an equally strong desire to maximise his 356 life expectancy. For some however the tension between social integration andM A N U S C R I P T The notion of 'giving back' within the data was therefore found to be complex with 366 gestures potentially disproportionate to the physical risk of biomarker led care. 367
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Often participants revealed the internal negotiation of anticipated downsides and 368
rewards. 'Giving-back' was hence emotionally charged, often linked to feelings of 369 responsibility and 'doing the right thing' and formed part of an assemblage of 370 considerations that collectively configured the level of risk a patient was prepared to 371 take. 372 373
The notion of 'trust' 374
Zinn (2008) describes trust as relying on experienced-based and tacit knowledge, 375
which in turn is influenced by personal context and feelings or beliefs, producing a 376 multi-layered concept. In the contemporary world, with its rising complexity, he 377 views trust as increasingly required, including trust in experts with appropriate 378 knowledge and skills (ibid:442). Certainly our data pointed to the prominence of 379 concepts of 'trust', 'belief' and 'faith', reflecting Zinn's views that these notions are 380 relied upon when clear evidence is unavailable. For example, a deeply emotionalM A N U S C R I P T By treating patients as individuals we ignore harms incurred by family members and 444 may as a consequence damage relationships (Hardwig 1990) . 445
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We had envisaged that familial negotiation would be higher in the case of a living 446 donation from a family member or friend. However, this was not evident in our data.
For example although Oliver (50%) and his mother had become "closer" since her 448 donation this had not translated into a low level of risk taking: 449
Pam: ….. it would be obviously his decision. I mean he's saying that he would 450 be more willing to take risks. I think I would be a little bit more reserved than 451
that. 452
It would appear therefore that it may not be the origin of the graft per se that leads 453 to familial negotiation but for some the necessity to discuss risk within relationships. 454
Luke whose wife donated a kidney to him 8 years ago explained: 455
Luke (0%): I know it's my body and all that, but it doesn't work like that. ….. 456 we've been married now over thirty years, it just doesn't work like that. 457
We're a team and I would never agree to something if she wasn't in With graft rejection being a major consideration for kidney transplant patients it was 499 understandable that many patients chose to continue with their current 500 immunosuppressant treatment. This was based on more than analytical decisions 501 with patients "feeling" that their graft was "settled", "comfortable" or "in a nice 502 routine", echoing the 'gut feeling' that Lupton speaks of (Lupton 2013:635) . 503
Considering that one of the downsides to rejection may possibly be a return to 504 dialysis it is further reasonable to argue that the emotion of experience played a role 505 in patient's decisions. 506
507
For some people these emotional and practical considerations appeared to have a 508 strong influence on their risk preference, leading them to opt for the "status quo". 509
However a number of patients were prepared to take a higher risk drawn by even 510 stronger feelings or concerns. For a few it was a reduction in symptom burden and 511 the effect this had on their life. However the small number considering issues of 512 symptom burden and the adverse effects of immunosuppressive drugs may have 513 been influenced by a lack of in-depth knowledge of the drugs significant adverse 514 effects. In addition the study was restricted to patients with 'stable' kidney function 515 whereas patients with unstable function and a heavier symptom burden may have 516 perceived greater medical gain and been prepared to take a higher risk. Taussig is pointing to the social relations embedded in disease, and their therapies, 543
and highlighting the synthesis of the moral, social and physical presentations. 544
According to Taussig in modern clinical practice and medical culture this function is 545 camouflaged, concealed by the aura of benevolence and to openly discuss that 546 which is camouflaged would be to undermine the stability of the present clinical 547 practice and to question the presently accepted relationship between clinician and 548 patient. By doing so we would undermine a stable reality that cannot be denied as 549 long as professional expertise bears down, as long as authorship is 'denied' and 550 reciprocity makes its presence felt (Taussig 1990 :5). Taussig's argument therefore 551 brings into question the value of trust when intent is camouflaged. We did however 552 note that trust does not necessarily lead to action, it could be voiced but did not 553 necessarily translate into a high-risk level. This indicated that feelings of trust and 554 faith may not preclude stronger emotions or rationales from shaping decisions. 555
556
The social space of kidney transplantation influences not only trust but also emotion 557 and the desire to 'give back', to 'reciprocate'. In hospital renal clinics where 558 conversations with medical professionals and indeed other patients focus on 559 creatinine levels, drug adherence and other medically induced phenomena 560 enrolments in clinical trials take place. One participant described the collective 561 experience as requiring her to be the "good kidney patient". This we argue 562 incorporates the notion of the patient as one who although aware of health risks -563 for example adhering to medication regimes) -is one who is prepared to take risks to 564 be involved in medical research and one who also appreciates they are the recipientM A N U S C R I P T
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25 of a 'gift' which as (Mauss 1954 ) describes carries its obligations to reciprocate. 566
These notions are important for as Lupton (2013) argues when patients weigh up 567 risks, or decide to take a risk, they are making assessments of the social meaning of 568 the phenomena, making sense of the situation and the risk. This takes into account 569 that although the risk may be material it is always interpreted via a social or cultural 570 lens reflecting amongst other things moral judgements within the particular 571 historical, social, cultural and political context (Lupton 2013b:638) . Regardless of risk 572 levels many participants made reference to the obligation they felt to reciprocate in 573 some manner for the 'gift' they had been given. For some this went hand-in-hand 574 with a risk level of 50% raising questions concerning the central place of exchange 575 and co-operation in society and the role this plays in kidney patients agreeing to 576 participate in medical research. If one considers 'gift exchange' as a social fact then 577
Durkheim's argument (1982) is of great relevance, e.g. that the manner of acting, 578 thinking and feeling that constitutes the social fact (in our case 'gift exchange') is 579 invested with a coercive power by virtue of which it exercises control over the 580 individual. This line of argument may explain the almost sacrificial attitude of some 581 participants and alludes to the way that emotional appeal cannot be divorced from 582 decision-making, despite medicines focus on rational scientific thought. It also raises 583 questions concerning the loss of dignity if one is unable to meet the obligation of 584 reciprocity and how patients may feel this keenly during patient-doctor encounters 585 or amongst fellow transplant patients and donors. 586
587
Our participants were also aware that treatments for renal failure have improved 588 because of the willingness of patients to take a risk with new and novel approachesM A N U S C R I P T
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and that they themselves might benefit from current research. Coupled with this is 590 the value reciprocation may have in obtaining resources needed for future life and 591 the maintaining of social bonds within the clinic. For example we need to understand 592 how patients perceive the relationship between research studies and organ 593 allocation and how this affects their risk judgement. This is of particular relevance to 594 kidney transplantation where organs fail and it is not unheard of for patients to 595 require up to three grafts. 596
597
Lupton describes risk judgements as shared and collective rather than located within 598 the individual (Lupton 2013:644) . Similarly our findings reflect the affect that 'others' 599 perspectives have on the assemblage. These include health professionals together 600 with the influence of familial opinion, with risk levels often mediated to take into 601 account family feelings and responsibilities. 602 603
Conclusion 604
Our interviews with transplant patients support the notion that emotion is not part 605 of a linear process preceding and separate to reason but intertwined with the 606 understanding and perception of risk. Acknowledging the shaping of risk-taking in 607 this way helps to appreciate the interplay that occurs between different factors that 608 patients take into account when making risk assessments. It also challenges the 609 perception of risk-taking by patients as based purely upon a rational weighing of 610 medical benefit, for example the reduction of symptoms or improved long-term 611 health. By so doing the study raises important questions concerning the influence 612 that emotion, social structures and concepts have on the level of risk a patient mayM A N U S C R I P T
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27 be prepared to take when invited to enrol in clinical trials. It also opens up the 614 possibility that patient choice is based on influences that may not accord with the 615 framework and intention of medical professionals and medical research. Although 616
Lupton reminds us that expert judgement is neither free of emotional involvement, 617 and science itself is inevitably an emotional enterprise, there is still the need to 618 consider the ways in which research within the arena of clinical medicine may 619 produce a tension arising from a collision with patients and familial frameworks. 620
621
The field of kidney transplantation is to a certain extent peculiar in the medical 622 domain with notions of repeated transplantation and requirements for organ 623 donation. As a consequence the individual factors that influenced our participants' 624 decision-making may not be applicable across medicine. However we argue that the 625 notion of the 'emotion-risk assemblage' is and provides a tool to enable discussion 626 and explanation of medical risk-taking particularly in the field of clinical trials. Our 627 research highlights the need when health choices are being made to couple 628 information provision with counselling for patients when health choices are being 629 made to help patients chose an option that best accommodates their physical health 630 and personal interpretation of the risk they may be taking. This would provide a 631 conduit between the patient's 'emotion-risk assemblage' and the intended scientific 632 rationale of the medical research and ensure a space for patient and medical 633 professionals to unpack and discuss the best available option. 
